AKT1 and Alzheimer disease: More importantly, anti-diabetic drugs have been shown to prevent amyloid beta neurotoxicity in AD models through the activation of the PI3K-AKT pathway (Cai et al., 2014; Liu et al., 2016; Tumminia et al., 2018).